Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVETIRACETAM Cause Psychomotor hyperactivity? 247 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 247 reports of Psychomotor hyperactivity have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.4% of all adverse event reports for LEVETIRACETAM.

247
Reports of Psychomotor hyperactivity with LEVETIRACETAM
0.4%
of all LEVETIRACETAM reports
6
Deaths
110
Hospitalizations

How Dangerous Is Psychomotor hyperactivity From LEVETIRACETAM?

Of the 247 reports, 6 (2.4%) resulted in death, 110 (44.5%) required hospitalization, and 2 (0.8%) were considered life-threatening.

Is Psychomotor hyperactivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 247 reports have been filed with the FAERS database.

What Other Side Effects Does LEVETIRACETAM Cause?

Seizure (9,961) Drug ineffective (8,666) Off label use (5,789) Maternal exposure during pregnancy (3,197) Foetal exposure during pregnancy (2,604) Epilepsy (2,546) Generalised tonic-clonic seizure (2,276) Somnolence (2,070) Fatigue (1,972) Status epilepticus (1,883)

What Other Drugs Cause Psychomotor hyperactivity?

METHYLPHENIDATE (617) QUETIAPINE (412) ARIPIPRAZOLE (389) OLANZAPINE (366) SERTRALINE (288) MONTELUKAST (282) RISPERIDONE (277) VENLAFAXINE (214) LEVOTHYROXINE (211) LORAZEPAM (197)

Which LEVETIRACETAM Alternatives Have Lower Psychomotor hyperactivity Risk?

LEVETIRACETAM vs LEVOBUNOLOL LEVETIRACETAM vs LEVOBUPIVACAINE LEVETIRACETAM vs LEVOCARNITINE LEVETIRACETAM vs LEVOCETIRIZINE LEVETIRACETAM vs LEVODOPA

Related Pages

LEVETIRACETAM Full Profile All Psychomotor hyperactivity Reports All Drugs Causing Psychomotor hyperactivity LEVETIRACETAM Demographics